These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20824412)

  • 21. Mast Cells, Mastocytosis, and Related Disorders.
    Theoharides TC; Valent P; Akin C
    N Engl J Med; 2015 Nov; 373(19):1885-6. PubMed ID: 26535528
    [No Abstract]   [Full Text] [Related]  

  • 22. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
    Golden DBK; Carter MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular defects in mastocytosis: KIT and beyond KIT.
    Bibi S; Langenfeld F; Jeanningros S; Brenet F; Soucie E; Hermine O; Damaj G; Dubreuil P; Arock M
    Immunol Allergy Clin North Am; 2014 May; 34(2):239-62. PubMed ID: 24745672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
    Akin C
    J Mol Diagn; 2006 Sep; 8(4):412-9. PubMed ID: 16931579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H1-antihistamines for primary mast cell activation syndromes: a systematic review.
    Nurmatov UB; Rhatigan E; Simons FE; Sheikh A
    Allergy; 2015 Sep; 70(9):1052-61. PubMed ID: 26095756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
    Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
    Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mastocytosis: advances in diagnosis and treatment.
    Hungness SI; Akin C
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):248-54. PubMed ID: 17547845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mastocytosis.
    Metcalfe DD
    Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
    Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R; Butterfield J
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review.
    Jenkinson HA; Lundgren AD; Carter MC; Diaz LZ; Levy ML
    Pediatr Dermatol; 2019 Jul; 36(4):486-489. PubMed ID: 30828864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
    Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
    J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.
    Mallet AI; Norris P; Rendell NB; Wong E; Greaves MW
    Br J Clin Pharmacol; 1989 Jan; 27(1):88-91. PubMed ID: 2495814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mastocytosis: from a Molecular Point of View.
    Komi DEA; Rambasek T; Wöhrl S
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.
    Volertas S; Schuler CF; Akin C
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current state of biology and diagnosis of clonal mast cell diseases in adults.
    Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L
    Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mastocytosis: review of clinical and experimental aspects.
    Hartmann K; Bruns SB; Henz BM
    J Investig Dermatol Symp Proc; 2001 Nov; 6(2):143-7. PubMed ID: 11764303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
    Nanagas VC; Kovalszki A
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.